Cargando…
A novel prognostic model based on four circulating miRNA in diffuse large B‐cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression
MicroRNA (miRNA) have been emerged as prognostic biomarkers in diffuse large B‐cell lymphoma (DLBCL). To understand the potential underlying mechanisms and translate these findings into clinical prediction on lymphoma progression, large patient cohorts should be evaluated. Here, using miRNA PCR arra...
Autores principales: | Sun, Rui, Zheng, Zhong, Wang, Li, Cheng, Shu, Shi, Qing, Qu, Bin, Fu, Di, Leboeuf, Christophe, Zhao, Yan, Ye, Jing, Janin, Anne, Zhao, Wei‐Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782091/ https://www.ncbi.nlm.nih.gov/pubmed/33107145 http://dx.doi.org/10.1002/1878-0261.12834 |
Ejemplares similares
-
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
por: Xu, Peng-Peng, et al.
Publicado: (2017) -
Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma
por: Lu, Ting, et al.
Publicado: (2016) -
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Lopez-Santillan, Maria, et al.
Publicado: (2018) -
MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
por: Yan, Zi-Xun, et al.
Publicado: (2015) -
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
por: Ji, Meng-Meng, et al.
Publicado: (2018)